Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1968 Jun;22(2):176–183. doi: 10.1038/bjc.1968.25

A clinical trial of mithramycin in the treatment of advanced malignant disease.

M Baum
PMCID: PMC2008246  PMID: 4873186

Full text

PDF
182

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. HOLSTI L. R. SERUM ENZYME ACTIVITY DURING RADIOTHERAPY OF MALIGNANT TUMOURS. Br J Cancer. 1965 Mar;19:134–138. doi: 10.1038/bjc.1965.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Parsons V., Baum M., Self M. Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease. Br Med J. 1967 Feb 25;1(5538):474–477. doi: 10.1136/bmj.1.5538.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. SPEAR P. W. Clinical trial with mithramycin. Cancer Chemother Rep. 1963 May;29:109–110. [PubMed] [Google Scholar]
  4. Sewell I. A., Ellis H. A trial of mithramycin in the treatment of advanced malignant disease. Br J Cancer. 1966 Jun;20(2):256–263. doi: 10.1038/bjc.1966.32. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES